NRC Health/$NRC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About NRC Health
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
- Ticker
- $NRC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 357
- Headquarters
- Lincoln, United States
- Website
- www.nrchealth.com
NRC Health Metrics
BasicAdvanced
$549M
96.48
$0.27
0.24
$0.64
2.47%
Price and volume
Market cap
$549M
Beta
0.24
52-week high
$27.41
52-week low
$11.74
Average daily volume
108K
Dividend rate
$0.64
Financial strength
Current ratio
0.638
Quick ratio
0.453
Long term debt to equity
-10.758
Total debt to equity
-11.28
Dividend payout ratio (TTM)
209.16%
Interest coverage (TTM)
3.51%
Profitability
EBITDA (TTM)
27.719
Gross margin (TTM)
60.69%
Net profit margin (TTM)
4.48%
Operating margin (TTM)
13.36%
Effective tax rate (TTM)
38.73%
Revenue per employee (TTM)
$400,000
Management effectiveness
Return on assets (TTM)
8.74%
Return on equity (TTM)
248.11%
Valuation
Price to earnings (TTM)
96.481
Price to revenue (TTM)
3.926
Price to book
-60.16
Price to tangible book (TTM)
-7.29
Price to free cash flow (TTM)
30.598
Free cash flow yield (TTM)
3.27%
Free cash flow per share (TTM)
0.845
Dividend yield (TTM)
2.47%
Forward dividend yield
2.47%
Growth
Revenue change (TTM)
3.37%
Earnings per share change (TTM)
-62.25%
3-year revenue growth (CAGR)
-1.12%
10-year revenue growth (CAGR)
2.96%
3-year earnings per share growth (CAGR)
-38.62%
10-year earnings per share growth (CAGR)
-10.75%
3-year dividend per share growth (CAGR)
10.06%
10-year dividend per share growth (CAGR)
7.18%
What the Analysts think about NRC Health
Analyst ratings (Buy, Hold, Sell) for NRC Health stock.
Analyst projections of the future price of NRC Health stock.
Bulls say / Bears say
Third-quarter revenue rose 11% to $38.4 million, net income increased to $4.7 million and free cash flow was $7.0 million. That is a much stronger result than the cash-flow performance in the previous quarter. (SEC)
Recurring contract value grew 9% to $154.1 million, and several long-standing customers renewed on multi-year agreements. That supports revenue visibility as new contracts convert into reported sales. (SEC)
NRC is developing AI tools around its long-running healthcare experience data, including features to help care teams capture and act on patient-rounding feedback. If customers adopt them, these tools could make the platform more useful and create room to sell more solutions to existing clients. (The Motley Fool)
Recurring contract value growth slowed to 9% in the third quarter from 11% in the second, and management said buyer uncertainty had paused some sales processes. Slower contract growth could weaken future revenue once current implementations roll through. (The Motley Fool, NRC Health)
For the first nine months, operating income fell 37% and operating cash flow fell 14% year on year, while selling, general and administrative costs rose 20%. That shows the strong third quarter has not yet reversed the broader pressure on earnings and cash generation. (StockTitan)
The company ended September with only $3.6 million of cash against roughly $103 million of loans. It also spent $16.7 million on share repurchases in the third quarter, which may limit financial flexibility if growth or cash generation falters. (StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.
NRC Health Financial Performance
Revenues and expenses
NRC Health Earnings Performance
Company profitability
Upcoming events
NRC Health News
AllArticlesVideos

National Research Q3 Earnings Call Highlights
MarketBeat1 week ago

NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
Business Wire2 weeks ago

New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
Business Wire3 weeks ago
Funds containing NRC Health
Fund name | Fund size | $NRC weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.01% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.